You are here

  • Home
  • Archive
  • Volume 12, Issue 1
  • Celecoxib versus placebo as an adjunct to treatment-as-usual in children and youth with obsessive–compulsive disorder: protocol for a single-site randomised quadruple-blind phase II study

Article metrics

Article menu

Download PDFPDF

Mental health
Protocol
Celecoxib versus placebo as an adjunct to treatment-as-usual in children and youth with obsessive–compulsive disorder: protocol for a single-site randomised quadruple-blind phase II study

 

Online download statistics by month:

Online download statistics by month: January 2022 to April 2024

AbstractFullPdf
Jan 202232320
Feb 202227926622
Mar 202213112411
Apr 202269596
May 202261554
Jun 202225235
Jul 202228221
Aug 202236304
Sep 202228226
Oct 202234287
Nov 2022292820
Dec 2022545120
Jan 2023312714
Feb 2023575822
Mar 2023343514
Apr 2023292718
May 2023322417
Jun 2023282615
Jul 202327269
Aug 2023383816
Sep 202343436
Oct 2023292414
Nov 202328235
Dec 2023543611
Jan 2024353610
Feb 2024242211
Mar 2024504011
Apr 2024151016
Total13601235315